Promotion of colonization and virulence by cholera toxin is dependent on neutrophils

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3338-3345

  Queen, Jessica ^a   Satchell, Karla J F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CHOLERA VACCINE; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE INFLAMMATORY PROTEIN 2 ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LY6G IA8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHOLERA; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE INFECTION; MOUSE; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SMALL INTESTINE; SURVIVAL RATE; VIBRIO CHOLERAE;

EID: 84884238469     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00422-13     Document Type: Article

References (48)

1. Sack DA, Sack RB, Nair GB, Siddique AK. 2004. Cholera. Lancet 363:223-233.
2. Vanden Broeck D, Horvath C, De Wolf MJ. 2007. Vibrio cholerae: cholera toxin. Int. J. Biochem. Cell Biol. 39:1771-1775.
3. Kaper JB, Morris JG, Jr, Levine MM. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86.
4. Levin BR, Tauxe RV. 1996. Cholera: nice bacteria and bad viruses. Curr. Biol. 6:1389-1391.
5. Waldor MK, Mekalanos JJ. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914.
6. Levine MM, Kaper JB, Herrington D, Ketley J, Losonsky G, Tacket CO, Tall B, Cryz S. 1988. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet ii:467-470.
7. Bubshait SA, Al-Turki K, Qadri MH, Fontaine RE, Cameron D. 2000. Seasonal, nontoxigenic Vibrio cholerae O1 Ogawa infections in the Eastern Region of Saudi Arabia. Int. J. Infect. Dis. 4:198-202.
8. Morris JG, Jr, Picardi JL, Lieb S, Lee JV, Roberts A, Hood M, Gunn RA, Blake PA. 1984. Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. J. Clin. Microbiol. 19:296-297.
9. Ma AT, Mekalanos JJ. 2010. In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc. Natl. Acad. Sci. U. S. A. 107:4365-4370.
10. Rui H, Ritchie JM, Bronson RT, Mekalanos JJ, Zhang Y, Waldor MK. 2010. Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins. Proc. Natl. Acad. Sci. U. S. A. 107:4359-4364.
11. Restrepo D, Huprikar SS, VanHorn K, Bottone EJ. 2006. O1 and non-O1 Vibrio cholerae bacteremia produced by hemolytic strains. Diagn. Microbiol. Infect. Dis. 54:145-148.
12. Bandyopadhaya A, Bhowmick S, Chaudhuri K. 2009. Activation of proinflammatory response in human intestinal epithelial cells following Vibrio cholerae infection through PI3K/Akt pathway. Can. J. Microbiol. 55:1310-1318.
13. Olivier V, Haines GK, III, Tan Y, Satchell KJ. 2007. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains. Infect. Immun. 75:5035-5042.
14. Olivier V, Salzman NH, Satchell KJ. 2007. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect. Immun. 75:5043-5051.
15. Olivier V, Queen J, Satchell KJ. 2009. Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins. PLoS One 4:e7352. doi:10.1371/journal.pone.0007352.
16. Fullner KJ, Boucher JC, Hanes MA, Haines GK, III, Meehan BM, Walchle C, Sansonetti PJ, Mekalanos JJ. 2002. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J. Exp. Med. 195:1455-1462.
17. Queen J, Satchell KJ. 2012. Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection. Infect. Immun. 80:2905-2913.
18. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83:64-70.
19. Mekalanos JJ, Swartz DJ, Pearson GD, Harford N, Groyne F, de Wilde M. 1983. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306:551-557.
20. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
21. Jackson RJ, Fujihashi K, Xu-Amano J, Kiyono H, Elson CO, McGhee JR. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272-4279.
22. Bowman CC, Clements JD. 2001. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids. Infect. Immun. 69:1528-1535.
23. Nygren E, Li BL, Holmgren J, Attridge SR. 2009. Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae. Infect. Immun. 77:3475-3484.
24. Houot L, Chang S, Absalon C, Watnick PI. 2010. Vibrio cholerae phosphoenolpyruvate phosphotransferase system control of carbohydrate transport, biofilm formation, and colonization of the germfree mouse intestine. Infect. Immun. 78:1482-1494.
25. Ali M, Lopez AL, You YA, Kim YE, Sah B, Maskery B, Clemens J. 2012. The global burden of cholera. Bull. World Health Organ. 90:209-218A.
26. Flach CF, Qadri F, Bhuiyan TR, Alam NH, Jennische E, Lonnroth I, Holmgren J. 2007. Broad up-regulation of innate defense factors during acute cholera. Infect. Immun. 75:2343-2350.
27. Qadri F, Bhuiyan TR, Dutta KK, Raqib R, Alam MS, Alam NH, Svennerholm AM, Mathan MM. 2004. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Gut 53:62-69.
28. Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, Das SK, Alam NH, Mathan MM, Svennerholm AM. 2002. Increased levels of inflam-matory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 9:221-229.
29. Silva TM, Schleupner MA, Tacket CO, Steiner TS, Kaper JB, Edelman R, Guerrant R. 1996. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae. Infect. Immun. 64:2362-2364.
30. Garcia-Ramallo E, Marques T, Prats N, Beleta J, Kunkel SL, Godessart N. 2002. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J. Immunol. 169:6467-6473.
31. Godbout C, Bilodeau R, Van Rooijen N, Bouchard P, Frenette J. 2010. Transient neutropenia increases macrophage accumulation and cell proliferation but does not improve repair following intratendinous rupture of Achilles tendon. J. Orthop. Res. 28:1084-1091.
32. Bromander A, Holmgren J, Lycke N. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908-2914.
33. Bromander AK, Kjerrulf M, Holmgren J, Lycke N. 1993. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 37:452-458.
34. Cong Y, Oliver AO, Elson CO. 2001. Effects of cholera toxin on macrophage production of co-stimulatory cytokines. Eur. J. Immunol. 31:64-71.
35. + dendritic cell differentiation by cAMPmediated inhibition of IRF8 function. J. Exp. Med. 206:1227-1235.
36. Lee JB, Jang JE, Song MK, Chang J. 2009. Intranasal delivery of cholera toxin induces Th17-dominated T-cell response to bystander antigens. PLoS One 4:e5190. doi:10.1371/journal.pone.0005190.
37. Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee JR. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621-4629.
38. Jeong HG, Satchell KJ. 2012. Additive function of Vibrio vulnificus MARTX(Vv) and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection. PLoS Pathog. 8:e1002581. doi:10.1371/journal.ppat.1002581.
39. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL, Sterzenbach T, Tsolis RM, Roth JR, Baumler AJ. 2011. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc. Natl. Acad. Sci. U. S. A. 108:17480-17485.
40. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams LG, Tsolis RM, Roth JR, Baumler AJ. 2010. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467:426-429.
41. Sung SS, Walters JA. 1991. Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes. J. Clin. Invest. 88:1915-1923.
42. Lee SH, Hava DL, Waldor MK, Camilli A. 1999. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:625-634.
43. Xu Q, Dziejman M, Mekalanos JJ. 2003. Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc. Natl. Acad. Sci. U. S. A. 100:1286-1291.
44. Nielsen AT, Dolganov NA, Rasmussen T, Otto G, Miller MC, Felt SA, Torreilles S, Schoolnik GK. 2010. A bistable switch and anatomical site control Vibrio cholerae virulence gene expression in the intestine. PLoS Pathog. 6:e1001102. doi:10.1371/journal.ppat.1001102.
45. Tsou AM, Zhu J. 2010. Quorum sensing negatively regulates hemolysin transcriptionally and posttranslationally in Vibrio cholerae. Infect. Immun. 78:461-467.
46. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. 2002. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc. Natl. Acad. Sci. U. S. A. 99:3129-3134.
47. Boardman BK, Meehan BM, Fullner Satchell KJ. 2007. Growth phase regulation of Vibrio cholerae RTX toxin export. J. Bacteriol. 189:1827-1835.
48. Ninin E, CaroffN, El Kouri D, Espaze E, Richet H, Quilici ML, Fournier JM. 2000. Nontoxigenic Vibrio cholerae O1 bacteremia: case report and review. Eur. J. Clin. Microbiol. Infect. Dis. 19:489-491.